By annette
Screening programs play a crucial role in identifying diseases before symptoms appear, offering the potential to improve health outcomes, reduce complications, and optimize the use of healthcare resources. Recent research advances have opened up new possibilities to screen for type 1 diabetes (T1D) and potentially delay disease onset among those at risk. However, before any …
By annette
ESMO Congress 2025 is the second largest oncology meeting in the world with over 20,000 attendees. From IHE, Urška Košir and Thomas Hofmarcher participated and presented in various events and sessions. Their presentations focused on a wide range of topics ranging from access to medicines to health promotion, health literacy and fertility preservation. Oral presentation: …
By annette
On 15 October, Europa Donna – The European Breast Cancer Coalition organized an event at the European Parliament to present a motion declaring 15 October as European Breast Health Day. The event hosted by MEPs Romana Jerković and Nicholas Papandreou brought together EU policymakers – including European Parliament President Roberta Metsola and former European Commissioner …
By annette
Cancer represents one of the greatest public health challenges in the world and in Algeria, its incidence continues to rise steadily. Cancer affects all segments of the population and has a profound impact on the health system, families, and society as a whole. This dashboard-style report for Algeria provides a visual and quantitative description of …
By annette
New publication in Journal of Journal of Comparative Effectiveness Research evaluating the cost-utility of real-time continuous glucose monitoring (rt-CGM) compared to intermittently scanned CGM (is-CGM) for insulin-treated adults with T2DM in Canada. Read more
By annette
Our colleague Thomas Hofmarcher contributed to The Lancet Series on the new clinical landscape in Alzheimer’s Disease (AD). Authored by 40 leading experts, the three-paper series summarizes our current understanding and highlights crucial next steps in diagnostics, treatment and prevention of AD. Read more and download the article
By annette
Women’s cancers – breast, cervical, ovarian, and uterine – represent a large and growing challenge worldwide. This IHE-report highlights the heavy health, social, and economic toll of women’s cancers – but also the strong return on investment when health systems act. Read more and download the report
By annette
How good is cancer care in Portugal compared to other EU countries and what can be improved? This dashboard-style report provides a visual and quantitative description of selected performance indicators in all areas of cancer care. It also highlights the importance of measuring and comparing a country’s performance in all areas of cancer care with …
By annette
The IHE Cancer Comparator Report 2025 took the center stage at the conference From Science to Access: Where are we in cancer care in 2025? in the European Parliament. The event was hosted by MEP Romana Jerković and organized by the EFPIA Oncology Platform. Thomas Hofmarcher set the scene by presenting the results of the …
By annette
The IHE Type 2 Diabetes Cohort Model (IHE-DCM-T2) is frequently used to estimate cost-effectiveness of interventions for type 2 diabetes in different parts of the world. The model has recently been updated to include Japan. Läs mer